Abstract
Premise: Migraine is a complex neurologic disorder that leads to significant disability, yet remains poorly understood. Problem: One potential triggering mechanism in migraine with aura is cortical spreading depression, which can activate the trigeminal nociceptive system both peripherally and centrally in animal models. A primary neuropeptide of the trigeminal system is calcitonin gene-related peptide, which is a potent vasodilatory peptide and is currently a major therapeutic target for migraine treatment. Despite the importance of both cortical spreading depression and calcitonin gene-related peptide in migraine, the relationship between these two players has been relatively unexplored. However, recent data suggest several potential vascular and neural connections between calcitonin gene-related peptide and cortical spreading depression. Conclusion: This review will outline calcitonin gene-related peptide-cortical spreading depression connections and propose a model in which cortical spreading depression and calcitonin gene-related peptide act at the intersection of the vasculature and cortical neurons, and thus contribute to migraine pathophysiology.
Original language | English |
---|---|
Pages (from-to) | 428-434 |
Number of pages | 7 |
Journal | Cephalalgia |
Volume | 39 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2019 |
Keywords
- cortical spreading depression
- Neurovasculature
- trigeminal nerve
- vasodilation